IDXX Idexx Laboratories Earnings and EPS analysis

?
Relative Growth: Rel. Growth: 91
Relative Strength: Rel. Strength: 28
Relative Valuation: Rel. Valuation: 28
Relative Profitability: Rel. Profitability: 96

EPS in 2026 (TTM): $13.7

Last Report Period Date: Mar 31, 2026

According to the most recent financial data from March 2026, the current EPS (TTM) is $13.7. Idexx Laboratories's EPS for 2025 came in at $13.17, marking an increase from $10.77 in 2024. For the quarterly period ending on Mar 31, 2026, IDXX's EPS was $3.5.

IDXX earnings history

Historical annual and quarterly earnings per share (EPS) data for Idexx Laboratories
EPS (TTM)
$13.7
EPS Growth YoY (Quarterly)
17.4%
EPS (Quarterly)
$3.5
EPS Growth (Quarterly)
12.5%

Idexx Laboratories had an annual EPS of $13.17, marking an increase of 22.3% from $10.77 in 2024. The quarterly EPS for the period ending Mar 31, 2026, was $3.5, marking a 17.4% increase from the same quarter last year. IDXX's TTM EPS stands at $13.7 as of March 2026. Idexx Laboratories's EPS for 2024 stood at $10.77, a 5.9% increase from 2023.

IDXX earnings chart

IDXX EPS growth history

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
17.4%
EPS growth YoY
22.3%
EPS growth 3Y avg
17.5%
EPS growth 5Y avg
14.1%

Idexx Laboratories has recorded an increase in EPS of 17.4% over the last 12 months (YoY, quarterly). For the last three years, IDXX recorded an average annual EPS growth rate of 17.5%. Idexx Laboratories had an average annual EPS growth rate of 14.1% over the last 5 years. Across the last decade, IDXX had an average annual EPS growth of 20.3%.

IDXX Earnings Waterfall

Breakdown of revenue, profit and net income for Idexx Laboratories

IDXX Earnings vs Peers

What are the earnings of IDXX compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
HSIC Henry Schein Inc 24.07 7.2% -5.9% 3.1%
ABT Abbott Laboratories 25.28 -51.4% -1.8% 8.2%
TMO Thermo Fisher Scientific Inc 25.59 7.2% 0% 2%
IDXX Idexx Laboratories Inc 39.49 22.3% 17.5% 14.1%
WOOF Petco Health & Wellness Company Inc 126.75 108.1% -55.5% N/A
NEOG Neogen Corp N/A -12,475% N/A N/A

All data is based on quarterly TTM periods, unless otherwise specified.